Creative Medical Technology Holdings, Inc.: Creative Medical Technology Holdings Granted FDA Clearance To Begin Phase 1/2 Clinical Trial Of AlloStem For Addressing Chronic Lower Back Pain finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ), a biotechnology company has received clearance from the FDA to conduct a phase 1/2 clinical trial using their innovative StemSpine® treatment known as AlloStem™.